Twentyeight Health Raises $5.1M in Seed Funding


Twentyeight Health, a NY-based telemedicine company for women’s sexual and reproductive health, raised $5.1M in seed funding round.

The round, which brought total funding to $6.6m, was led by Third Prime with participation from Town Hall Ventures, SteelSky Ventures, Aglaé Ventures, GingerBread Capital, Rucker Park Capital, Predictive VC and strategic angels including Stu Libby, Zoe Barry and Wan Li Zhu.

The company intends to use the funds to launch and grow its telemedicine and contraception prescription delivery services in new states, and offer additional products for sexual health.  

Launched in late 2018 by Amy Fan and Bruno Van Tuykom, Twentyeight Health is a telecontraception company that focuses on enabling access to sexual and reproductive care for underserved communities.  The company is also working to provide free birth control for women who are not able to pay out of pocket and are uninsured, through a partnership with Bedsider’s Contraceptive Access Fund.

To sign up for Twentyeight Health, new customers fill out a medical questionnaire online, which a U.S. board-certified doctor reviews within 24 hours. Online audio consultations are also available at no extra charge. Customers can access over 100 FDA-approved brands of birth control pills, patch, ring, shot and emergency contraception, and receive shipment within 1-3 business days. It provides ongoing care through unlimited doctor follow up messages to discuss issues such as updating prescriptions or addressing side effects.

The service is currently available across six states — Florida, Maryland, New York, New Jersey, North Carolina, and Pennsylvania — and accept Medicaid in these states.



Join the discussion